Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-93.15	-1.71	24.97
Graham Fair Price	16.10	312625.65	269281.36
PEG	-13.90	0.20	-0.24
Price/Book	4.22	0.55	0.53
Price/Cash Flow	-89.80	23.36	-229.01
Prices/Earnings	-19.47	6.61	8.20
Price/Sales	12.51	1.64	1.46
Price/FCF	-89.80	23.36	-229.01
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-6.21	0.12	0.12
Operating Margin	2267.17	-0.84	0.04
ROA	27.30	0.01	0.01
ROE	0.02	0.02	29.42
ROIC	< 0.005	-0.19	2149.89
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.09	-0.08	14.22
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	-0.24	-23.38	-9561.79
EPS QOQ	-0.35	0.32	-6.47
FCF QOQ	-1.08	11.43	958.74
Revenue QOQ	0.03	-0.05	76.21
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	38.61	43.50	12.65
Days Sales Outstanding (DSO)	62.67	65.19	4.03
Inventory Turnover	2.33	2.07	-11.23
Debt/Capitalization	0.05	0.06	6.59
Quick Ratio	1.61	1.56	-3.07
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	448163.96	457349.33	2.05
Cash	101498.60	110453.02	8.82
Capex	-7202.64	-6133.54	14.84
Free Cash Flow	-1030.52	10744.63	942.64
Revenue	161822.20	152966.05	-5.47
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.12	2.08	-2.15
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-3.05	0.23	-92.32
Naive Interpretation	Member

06 - Financial Health · Bad

Rating